Results 181 to 190 of about 3,606,010 (253)

Cell Therapy 2000: Introduction [PDF]

Cell Transplantation, 2001
openaire   +3 more sources

The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy. [PDF]

Ther Adv Neurol Disord
Lasocki A, Harrison SJ, Dickinson M, Kalincik T.   +3 more
europepmc   +1 more source

Chemosensitizing effect of apigenin on T-ALL cell therapy. [PDF]

Front Pharmacol
Huseynova N, Baran Z, Khalilov R, Mammadova A, Baran Y.   +4 more
europepmc   +1 more source

Cytokine Engineering in CAR-T Cell Therapy: Next-Generation Strategies. [PDF]

Immune Netw
Kim S, Heo SH, Baek H, Hwang SS.
europepmc   +1 more source

CAR-based cell therapy for autoimmune diseases. [PDF]

Front Immunol
Li X, He C, Wang K, Xu GY, Xie YC, Ying XY.   +5 more
europepmc   +1 more source

CAR-T cell therapy targeting MUC17 in gastric tumors. [PDF]

J Immunother Cancer
Park S, Ho CE, Birocchi F, Wolff AN, Bouffard AA, Kelly C, Salas-Benito D, Escobar G, Mucci A, Berger T, Maus MV.   +10 more
europepmc   +1 more source

Chimeric Antigen Receptor T-Cell Therapy and Autoimmune Diseases in the Nervous System. [PDF]

Immun Inflamm Dis
Yao SY, Du MQ, Yang H, Zeng QM, Zhou H, Zhang X, Kazuo S, Liu J, Lin LX, Kang XH, Jiang DY, Peng Y.   +11 more
europepmc   +1 more source

Alternative therapy for sickle cell disease

, 2015
Huda Alsultan
openalex   +1 more source

Dean migration mechanisms: facilitating the control of microbial contaminants in cell therapy product manufacturing. [PDF]

Microsyst Nanoeng
Tan J, Yang J, Huang J, Huang Z, Xu L, Yao W, Shen C, Zhao M, Zhou L.   +8 more
europepmc   +1 more source